cardiology careers collections past issues search home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 1 Effects of therapy on two-year mortality in landmark trials of heart failure of varying symptomatic severity. ßB = beta-blocker; AA = aldosterone antagonist; ACEi = angiotensin-converting enzyme inhibitor; NYHA = New York Heart Association; Prev. = Prevention; Treat. = Treatment. CIBIS-II = Cardiac Insufficiency Bisoprolol Study-part II; CONSENSUS = Cooperative North Scandinavian Enalapril Survival Study; COPERNICUS = Carvedilol Prospective Randomised Cumulative Survival trial; EPHESUS = Eplerenone's Neurohormonal Efficacy and Survival Study; MERIT = Metoprolol CR/XL Randomized Intervention Trial in Heart Failure; RALES = Randomized Aldactone Evaluation Study; SOLVD = Studies Of Left Ventricular Dysfunction.





Right arrow Return to article

 
  cardiology careers collections past issues search home